Bonafede MM - Search Results

1

Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis.

Feldman SR, Pelletier CL, Wilson KL, Mehta RK, Brouillette MA, Smith D, Bonafede MM. Feldman SR, et al. Among authors: bonafede mm. J Comp Eff Res. 2019 Jul;8(9):699-709. doi: 10.2217/cer-2019-0034. Epub 2019 May 13. J Comp Eff Res. 2019. PMID: 31081676 Free article.

2

Tumor necrosis factor blocker dose escalation among biologic naïve rheumatoid arthritis patients in commercial managed-care plans in the 2 years following therapy initiation.

Bonafede MM, Gandra SR, Fox KM, Wilson KL. Bonafede MM, et al. J Med Econ. 2012;15(4):635-43. doi: 10.3111/13696998.2012.667028. Epub 2012 Mar 1. J Med Econ. 2012. PMID: 22332705 Free article.

3

Incidence and cost of CAP in a large working-age population.

Bonafede MM, Suaya JA, Wilson KL, Mannino DM, Polsky D. Bonafede MM, et al. Am J Manag Care. 2012 Jul;18(7):380-7. Am J Manag Care. 2012. PMID: 22823532 Free article.

4

Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US population.

Ray S, Bonthapally V, McMorrow D, Bonafede M, Landsman-Blumberg P. Ray S, et al. J Comp Eff Res. 2013 Mar;2(2):195-206. doi: 10.2217/cer.13.1. J Comp Eff Res. 2013. PMID: 24236561 Free article.

5

Comparison of direct and indirect costs of abnormal uterine bleeding treatment with global endometrial ablation and hysterectomy.

Bonafede MM, Miller JD, Lukes A, Meyer NM, Lenhart GM. Bonafede MM, et al. J Comp Eff Res. 2015 Mar;4(2):115-22. doi: 10.2217/cer.14.81. Epub 2014 Dec 12. J Comp Eff Res. 2015. PMID: 25496448 Free article.

6

Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis.

Bonafede M, Johnson BH, Princic N, Shah N, Harrison DJ. Bonafede M, et al. J Med Econ. 2015 May;18(5):376-89. doi: 10.3111/13696998.2014.1001849. Epub 2015 Jan 28. J Med Econ. 2015. PMID: 25530318 Free article.

7

Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX.

McBride A, Bonafede M, Cai Q, Princic N, Tran O, Pelletier C, Parisi M, Patel M. McBride A, et al. Expert Rev Clin Pharmacol. 2017 Oct;10(10):1153-1160. doi: 10.1080/17512433.2017.1365598. Epub 2017 Aug 21. Expert Rev Clin Pharmacol. 2017. PMID: 28795609

8

Disease-modifying antirheumatic drug initiation among patients newly diagnosed with rheumatoid arthritis.

Bonafede M, Johnson BH, Shah N, Harrison DJ, Tang D, Stolshek BS. Bonafede M, et al. Am J Manag Care. 2018 Jul;24(8 Spec No.):SP279-SP285. Am J Manag Care. 2018. PMID: 30020740 Free article.

9

Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics.

Feldman SR, Pelletier CL, Wilson KL, Mehta RK, Brouillette MA, Smith D, Bonafede MM. Feldman SR, et al. Among authors: bonafede mm. J Comp Eff Res. 2019 Jan;8(1):45-54. doi: 10.2217/cer-2018-0097. Epub 2018 Nov 2. J Comp Eff Res. 2019. PMID: 30387367 Free article.

10

Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine.

Bonafede M, Wilson K, Xue F. Bonafede M, et al. Cephalalgia. 2019 Aug;39(9):1086-1098. doi: 10.1177/0333102419835465. Epub 2019 Feb 28. Cephalalgia. 2019. PMID: 30818974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters